Vagelos P Roy - Dec 8, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 04:35 PM
Previous filing
Aug 27, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +1.86K +0.59% $0.00 319K Dec 8, 2021 Direct F1
transaction REGN Common Stock Gift $0 -347 -0.24% $0.00 142K Oct 4, 2021 by CLAT
holding REGN Common Stock 2.22K Dec 8, 2021 By 401(k) Plan
holding REGN Common Stock 37.7K Dec 8, 2021 by Spouse as Trustee
holding REGN Common Stock 3.61K Dec 8, 2021 by trust for grandch F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +21.2K $0.00 21.2K Dec 8, 2021 Common Stock 21.2K $644.54 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
F2 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.